Tucker Medical, 8 Sinaran Drive, Suite 04-03, Singapore 307470  •  +65 6659 6918  •  [email protected]

What We're Reading

These pages are updated regularly with interesting articles that we've been reading on the subjects of cancer and, more importantly, disease prevention. We hope that you come back regularly to see what is new.

Prostate Cancer
Genetics Startup Helix Wants To Create A World Of Personalized Products From Your DNA | Fast Company Before his death from pancreatic cancer in 2011, Steve Jobs paid $100,000 to have his DNA sequenced. It was a rare and expensive move that, according to biographer Walter Isaacson, provided insight into potential treatments and allowed doctors to customize his drug regimen.
Men underestimate sexual dysfunction risks of prostate surgery Reuters Health - Men with sexual dysfunction after prostate cancer surgery are often surprised to learn that the surgery had put them at risk for those problems, a new study finds. The men in the study had come to a sexual health clinic because of problems they were having after removal of a cancerous prostate gland.
Liquid biopsy: Clues on prostate cancer drug resistance © 2015 American Association for the Advancement of Science. All rights Reserved. AAAS is a partner of HINARI, AGORA OARE, PatientInform, CHORUS, CLOCKSS, CrossRef and COUNTER. Science Translational Medicine ISSN 1946-6242.
Castration radiosensitizes prostate cancer tissue by impairing DNA double-strand break repair Chemical castration decreases Ku70 expression impairing nonhomologous end joining DNA repair and improving the radiotherapy response of prostate cancer patients.
Plasma AR and abiraterone-resistant prostate cancer Androgen receptor targeting is the cornerstone of prostate cancer treatment. Even when the tumors become "castration-resistant" or no longer sensitive to androgen deprivation, androgen signaling can still be effectively targeted by newer drugs such as abiraterone and enzalutamide, which also inhibit the androgen signaling axis. Romanel et al .
Study supports watch-and-wait approach for many prostate cancers (Reuters Health) - In a long-term study of older men diagnosed with low-risk prostate cancer and followed with active surveillance, less than a third of cases eventually needed treatment, according to a new study. About one half of one percent of the men died of their cancer during up to 18 years of follow-up.
LowGrade Prostate Cancers Rarely Metastasize In a study, not a single case of metastatic disease developed among 449 men who had a tumor grade of Gleason 6 or less at radical prostatectomy. Prostate cancer (PCa) patients with a tumor grade of Gleason 6 or less at the time of radical prostatectomy (R
More evidence breast cancer and prostate cancer cluster in families These findings, from the large Women's Health Initiative, reinforce the results of a 1994 study in the Journal of the National Cancer Institute, the authors write. "This is not the first study to examine this relationship, but it is one of the larger to d
Prostate cancer surgery may impair sex for both partners The researchers studied sexual function and satisfaction after men had a type of cancer surgery designed to remove the entire prostate, including semen glands, but protect nearby nerves that are involved in erections.
Can we use an anti-diabetic drug to treat cancer? Metformin is widely used to reduce the high blood sugar levels caused by diabetes. Recently, several studies have suggested that patients taking metformin who also develop cancer have tumors that grow more slowly than average. As clinical trials have alre
Study of Prostate Screenings: Investigators Respond Re " The Problem With Prostate Screening " (Op-Ed, Nov. 26): We were disheartened to read Dr. Richard J. Ablin accuse us, as investigators of the European Randomized Study of Screening for Prostate Cancer and the Goteborg randomized population-based prost
The Problem With Prostate Screening TUCSON - SCIENTIFIC data from clinical trials provides the foundation of medical decision making, from a doctor's prescription pad to sweeping public health policies. Public trust that the data is accurate and unbiased is the glue that binds our $3 trilli
High triglycerides linked with prostate cancer recurrence Among men who had surgery for prostate cancer, those with elevated triglyceride levels before surgery were 35% more likely to show signs of a cancer recurrence than men with normal preoperative levels. The study reinforces the benefits of maintaining a he
Prototype device diagnoses prostate cancer in minutes European research organization Fraunhofer is set to present a prototype device for quickly diagnosing prostate cancer at the COMPAMED trade fair in Düsseldorf next week. Its creators claim that it can reliably determine whether changed tissue in the prost
Can Aspirin Cut Your Risk of Cancer? - US News You know that white pill in your medicine cabinet? It could help to reduce your risk of cancer. It might be hard to believe that the little white pill you've probably taken primarily for headache relief could be powerful enough to stave off a disease as d
How Diet Can Lower Risk of Prostate Cancer Tomato and bean consumption helps prevent the disease Consuming more than ten servings a week of tomatoes and beans lowers the risk of prostate cancer, according to a new study from researchers at the University of Bristol.
The lab that created Spark wants to speed up everything, including cures for cancer A A Unknown to most of the world, the University of California, Berkeley's AMPLab has already left an indelible mark on world of information technology, and even the web. But we haven't yet experienced full impact of the group, which launched in 2011 unde
What Is Personalized Medicine? You go to your doctor with your symptoms, and you get an evaluation, maybe have a few tests run. If you are lucky, you're on your way to a diagnosis and a path to feeling better. How much more personal does it get? In fact, much more. In theory, astonishi
Robotic surgery news & marketing - misrepresentation of evidence "Under the glare of an operating theatre lamp...." Here it comes: another drooling, fawning news story about robotic surgery - this time from The Guardian in the UK under the headline, " Newcastle hospital's £2m robot transforms medical operations ." It w